FIELD: chemistry.
SUBSTANCE: invention relates to pharmaceutics and medicine and use of tricyclic imidazo[1,2-a]benzimidazole derivatives of general formula I 
or 1,3-disubstituted 2-aminobenzimidazolium halides of general formula II 
as an agent having cardioprotective action with high efficiency.
EFFECT: high efficiency.
3 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM | 2013 |
|
RU2518741C1 |
| METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE | 2013 |
|
RU2518740C1 |
| DERIVATIVES OF QUINAZOLIN-4(3H)-ONE INHIBITING SODIUM-HYDROGEN EXCHANGE | 2016 |
|
RU2654062C2 |
| KAPPA-OPIOID AGONIST | 2009 |
|
RU2413512C1 |
| SALTS OF 9-(2-MORPHOLINOETHYL)-2-(4-FLUOROPHENYL)IMIDAZO [1,2-a]BENZIMIDAZOLE AND SALTS OF 9-AMINOETHYL-SUBSTITUTED -(4-FLUOROPHENYL)IMIDAZO [1,2-a]BENZIMIDAZOLE, HAVING ANALGESIC ACTION | 2009 |
|
RU2412187C1 |
| (1Z,3Z)-4-ARYL-4-HYDROXY-1-(3,3-DIALKYL-3,4-DIHYDROISOQUINOLIN-1(2N)-YLIDENE)-BUT-3-EN-4-ONES AND METHOD OF PRODUCING SAID COMPOUNDS | 2008 |
|
RU2374231C1 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| METHOD FOR INCREASING MOTION ACTIVITY AT CLINICAL STAGE OF REHABILITATION IN GERIATRIC PATIENTS WITH MYOCARDIAL INFARCTION, HOWEVER SUFFERED NO CORONARY REPERFUSION AND REVASCULARISATION | 2014 |
|
RU2546410C1 |
| METHOD OF PRODUCING HYDRAZONES OF NITRO-TETRAZOLE-5-CARBALDEHYDE | 2012 |
|
RU2522437C2 |
| DERIVATIVES OF QUINAZOLINE-4 (3H)-ONE, WITH NEURO- AND CARDIOPROTECTIVE ACTIVITY | 2016 |
|
RU2622638C1 |
